Evidence map›Paper›PMID 38386156›Full record

ReviewAbdominal radiology (New York)2024

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications.

Shamus Moran, Heather H Cheng, Emily Weg, Eric H Kim, Delphine L Chen, Amir Iravani, Joseph E Ippolito

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shamus MoranDepartment of Radiology, University of Washington School of Medicine, Seattle, WA, USA.
Heather H ChengDivision of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Emily WegDepartment of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
Eric H KimDivision of Urologic Surgery, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Delphine L ChenDivision of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA.
Amir IravaniDivision of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA.
Joseph E IppolitoMallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, 4559 Scott Ave., Mail Stop Code: 8131, St. Louis, MO, 63110, USA. ippolitoj@wustl.edu.ORCID 0000-0003-1913-5573

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) is transforming the management of patients with prostate cancer. In appropriately selected patients, PSMA-PET offers superior sensitivity and specificity compared to conventional imaging (e.g., computed tomography and bone scintigraphy) as well as choline and fluciclovine PET, with the added benefit of consolidating bone and soft tissue evaluation into a single study. Despite being a newly available imaging tool, PSMA-PET has established indications, interpretation guidelines, and reporting criteria, which will be reviewed. The prostate cancer care team, from imaging specialists to those delivering treatment, should have knowledge of physiologic PSMA radiotracer uptake, patterns of disease spread, and the strengths and limitations of PSMA-PET. In this review, current and emerging applications of PSMA-PET, including appropriateness use criteria as well as image interpretation and pitfalls, will be provided with an emphasis on clinical implications.

Indexed as

ProstateProstatic NeoplasmsGallium RadioisotopesHumansMalePositron-Emission TomographyPositron Emission Tomography Computed TomographyGallium RadioisotopesImagingPET/CTProstate cancerPSMA

Identifiers

PMID38386156

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.